Centene/$CNC
1D1W1MYTD1Y5YMAX
Capital at risk
About Centene
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
- Ticker
- $CNC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 61,100
- Headquarters
- Saint Louis, United States
- Website
- www.centene.com
Centene Metrics
BasicAdvanced
$33B
-
-$10.36
1.08
-
Price and volume
Market cap
$33B
Beta
1.08
52-week high
$69.63
52-week low
$31.63
Average daily volume
3.9M
Financial strength
Current ratio
1.145
Quick ratio
1.107
Long term debt to equity
0.708
Total debt to equity
0.711
Interest coverage (TTM)
5.15%
Profitability
EBITDA (TTM)
4,606
Gross margin (TTM)
11.41%
Net profit margin (TTM)
-2.83%
Operating margin (TTM)
1.87%
Effective tax rate (TTM)
-10.23%
Revenue per employee (TTM)
$2,950,000
Management effectiveness
Return on assets (TTM)
2.49%
Return on equity (TTM)
-20.36%
Valuation
Price to revenue (TTM)
0.183
Price to book
1.47
Price to tangible book (TTM)
4.41
Price to free cash flow (TTM)
3.689
Free cash flow yield (TTM)
27.11%
Free cash flow per share (TTM)
18.188
Growth
Revenue change (TTM)
12.94%
Earnings per share change (TTM)
-354.74%
3-year revenue growth (CAGR)
9.30%
10-year revenue growth (CAGR)
20.45%
3-year earnings per share growth (CAGR)
29.04%
10-year earnings per share growth (CAGR)
23.12%
What the Analysts think about Centene
Analyst ratings (Buy, Hold, Sell) for Centene stock.
Analyst projections of the future price of Centene stock.
Bulls say / Bears say
Centene’s operating turnaround is gaining traction: second-quarter adjusted EPS was $2.51, the consolidated health benefits ratio improved to 89.6%, and management raised its 2026 adjusted EPS outlook to above $4.80. Better control of medical costs was also enough to support an earlier profit forecast increase. (Centene Corporation, Reuters)
The Marketplace business is expected to deliver a 4.5%–5% margin in 2026, while the Medicare Part D business is tracking towards a margin above 3%. Centene is also simplifying Medicare Advantage around dual-eligible and complex members, with a stated path to break-even or better in 2027. (Centene Corporation, StockAnalysis.com)
Centene retained a four-year Illinois Medicaid contract running from 2027 to 2030. Its Meridian subsidiary currently serves more than 596,000 members in the programme, giving the company a durable state-based platform even as overall Medicaid enrolment declines. (Centene Corporation)
Medicaid membership is now expected to fall 8%–9% in 2026, worse than the previous forecast, as states tighten eligibility ahead of work requirements. This threatens revenue scale and could leave Centene with a higher-acuity pool that is harder to insure profitably. (MarketBeat, Centene Corporation)
Centene faces several policy changes at once, including Medicaid work requirements, tighter eligibility checks and pressure on Medicare Star Ratings. Management still expects Medicare Advantage to reach break-even or better only in 2027, so the recovery remains exposed to regulation and rate-setting. (Healthcare Dive, MarketBeat)
The raised 2026 adjusted EPS outlook includes about $0.50 per share of non-recurring Medicare and Commercial items. Marketplace improvement also benefited from favourable risk adjustment, so reported earnings may overstate the sustainable run-rate once these gains fade. (Centene Corporation, Healthcare Dive)
Data summarised monthly by Lightyear AI. Last updated on 20 Sept 2026.
Centene Financial Performance
Revenues and expenses
Centene Earnings Performance
Company profitability
Upcoming events
No upcoming events
Centene News
AllArticlesVideos
Funds containing Centene
AllEURUSDGBP
Fund name | Fund size | $CNC weighting |
|---|---|---|
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.51% |
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 0.46% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.23% |
iShares MSCI USA SRI€QDVR | €2.9B | 0.23% |
iShares MSCI USA SRI£SUUS | £2.5B | 0.23% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.